Materials Healthcare Sector

Tenaya Therapeutics

Market Cap: US$70.7m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

Syntara

Market Cap: AU$108.8m

Operates as a clinical-stage drug development company that focuses on blood-related cancers in Australia.

Alcidion Group

Market Cap: AU$108.8m

Engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom.

Vistagen Therapeutics

Market Cap: US$70.1m

A biopharmaceutical company, engages in the development and commercialization of therapies for psychiatric and neurological disorders.

InspireMD

Market Cap: US$69.8m

A medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific.

Austco Healthcare

Market Cap: AU$107.4m

Operates as provider of healthcare communication solutions in Australia, New Zealand, Asia, Europe, and North America.

Zynex

Market Cap: US$69.5m

Designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation.

Elutia

Market Cap: US$69.5m

A commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States.

Surrozen

Market Cap: US$69.1m

A biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair.

Argenica Therapeutics

Market Cap: AU$106.3m

A biotechnology company, engages in the research and development of neuroprotective therapeutic drug in Australia.

Creo Medical Group

Market Cap: UK£50.3m

Through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments in the United Kingdom.

Assertio Holdings

Market Cap: US$68.0m

A pharmaceutical company, provides various products to patients in the United States.

BeyondSpring

Market Cap: US$67.7m

A clinical stage biopharmaceutical company, focuses on the development of cancer therapies.

MediciNova

Market Cap: US$67.7m

A biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.

Armata Pharmaceuticals

Market Cap: US$67.7m

Operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.

Vivani Medical

Market Cap: US$67.5m

A clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases.

EDAP TMS

Market Cap: US$67.3m

Develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally.

Clearside Biomedical

Market Cap: US$67.3m

A biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space.

Immix Biopharma

Market Cap: US$67.2m

A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.

Medicenna Therapeutics

Market Cap: CA$91.7m

An immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases.

Adlai Nortye

Market Cap: US$66.7m

A clinical-stage biotechnology company, engages in the research and development of pharmaceutical products.

Exicure

Market Cap: US$66.4m

Does not have significant operations.

Unicycive Therapeutics

Market Cap: US$65.7m

A clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States.

SDI

Market Cap: AU$101.0m

Engages in the research and development, manufacture, and marketing of dental restorative materials, whitening systems, and other dental materials in Australia, Europe, the United States, and Brazil.

EDX Medical Group

Market Cap: UK£48.5m

Engages in developing a range of diagnostics testing solutions in the United Kingdom.

Telomir Pharmaceuticals

Market Cap: US$65.5m

A pre-clinical stage biopharmaceutical company, focuses on developing pharmaceutical products for reversal of oxidative stress, cellular protection, and regulatory mechanism.

Citius Oncology

Market Cap: US$65.1m

Focuses on the development of novel targeted oncology therapies.

Seres Therapeutics

Market Cap: US$65.0m

A clinical-stage company, focuses on developing biotherapeutics for serious diseases.

Akoya Biosciences

Market Cap: US$64.8m

A life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa.

Vita Life Sciences

Market Cap: AU$99.3m

A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.

Zura Bio

Market Cap: US$64.3m

A clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States.

Jushi Holdings

Market Cap: US$64.3m

A vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States.

Skye Bioscience

Market Cap: US$64.1m

A clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases.

Forian

Market Cap: US$63.9m

Provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the life science, healthcare, and financial services industries.

Medexus Pharmaceuticals

Market Cap: CA$87.7m

Operates as a pharmaceutical company in Canada and the United States.

Nutriband

Market Cap: US$63.7m

Develops a portfolio of transdermal pharmaceutical products.